Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Odalys Gonzalez Paz

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Medicinal Chemistry|September 1, 2006
A structure-guided approach to an orthogonal estrogen-receptor-based gene switch activated by ligands suitable for in vivo studiesOlaf Kinzel, Daniela Fattori, Ester Muraglia, et al.
European Journal of Medicinal Chemistry|June 5, 2009
Cyclic phosphoramidates as prodrugs of 2'-C-methylcytidineMalte Meppen, Barbara Pacini, Renzo Bazzo, et al.
Cells|April 23, 2020
Establishment of an in Vitro Human Blood-Brain Barrier Model Derived from Induced Pluripotent Stem Cells and Comparison to a Porcine Cell-Based SystemAnnalise Di Marco, Domenico Vignone, Odalys Gonzalez Paz, et al.
Molecular Pharmaceutics|March 28, 2019
Application of an in Vitro Blood-Brain Barrier Model in the Selection of Experimental Drug Candidates for the Treatment of Huntington's DiseaseAnnalise Di Marco, Odalys Gonzalez Paz, Ivan Fini, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2003
Construction of an rtTA2(s)-m2/tts(kid)-based transcription regulatory switch that displays no basal activity, good inducibility, and high responsiveness to doxycycline in mice and non-human primatesStefania Lamartina, Luisa Silvi, Giuseppe Roscilli, et al.
Journal of Medicinal Chemistry|January 26, 2008
Design and synthesis of bicyclic pyrimidinones as potent and orally bioavailable HIV-1 integrase inhibitorsEster Muraglia, Olaf Kinzel, Cristina Gardelli, et al.
Journal of Colloid and Interface Science|July 19, 2022
Transport of cationic liposomes in a human blood brain barrier model: Role of the stereochemistry of the gemini amphiphile on liposome biological featuresBeatrice Simonis, Domenico Vignone, Odalys Gonzalez Paz, et al.
Journal of Medicinal Chemistry|April 13, 2007
Dihydroxypyrimidine-4-carboxamides as novel potent and selective HIV integrase inhibitorsPaola Pace, M Emilia Di Francesco, Cristina Gardelli, et al.
Journal of Medicinal Chemistry|September 4, 2008
Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infectionVincenzo Summa, Alessia Petrocchi, Fabio Bonelli, et al.
Journal of Medicinal Chemistry|September 11, 2007
Discovery and synthesis of HIV integrase inhibitors: development of potent and orally bioavailable N-methyl pyrimidonesCristina Gardelli, Emanuela Nizi, Ester Muraglia, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Medicinal Chemistry|September 1, 2006
A structure-guided approach to an orthogonal estrogen-receptor-based gene switch activated by ligands suitable for in vivo studiesOlaf Kinzel, Daniela Fattori, Ester Muraglia, et al.
European Journal of Medicinal Chemistry|June 5, 2009
Cyclic phosphoramidates as prodrugs of 2'-C-methylcytidineMalte Meppen, Barbara Pacini, Renzo Bazzo, et al.
Cells|April 23, 2020
Establishment of an in Vitro Human Blood-Brain Barrier Model Derived from Induced Pluripotent Stem Cells and Comparison to a Porcine Cell-Based SystemAnnalise Di Marco, Domenico Vignone, Odalys Gonzalez Paz, et al.
Molecular Pharmaceutics|March 28, 2019
Application of an in Vitro Blood-Brain Barrier Model in the Selection of Experimental Drug Candidates for the Treatment of Huntington's DiseaseAnnalise Di Marco, Odalys Gonzalez Paz, Ivan Fini, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2003
Construction of an rtTA2(s)-m2/tts(kid)-based transcription regulatory switch that displays no basal activity, good inducibility, and high responsiveness to doxycycline in mice and non-human primatesStefania Lamartina, Luisa Silvi, Giuseppe Roscilli, et al.
Journal of Medicinal Chemistry|January 26, 2008
Design and synthesis of bicyclic pyrimidinones as potent and orally bioavailable HIV-1 integrase inhibitorsEster Muraglia, Olaf Kinzel, Cristina Gardelli, et al.
Journal of Colloid and Interface Science|July 19, 2022
Transport of cationic liposomes in a human blood brain barrier model: Role of the stereochemistry of the gemini amphiphile on liposome biological featuresBeatrice Simonis, Domenico Vignone, Odalys Gonzalez Paz, et al.
Journal of Medicinal Chemistry|April 13, 2007
Dihydroxypyrimidine-4-carboxamides as novel potent and selective HIV integrase inhibitorsPaola Pace, M Emilia Di Francesco, Cristina Gardelli, et al.
Journal of Medicinal Chemistry|September 4, 2008
Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infectionVincenzo Summa, Alessia Petrocchi, Fabio Bonelli, et al.
Journal of Medicinal Chemistry|September 11, 2007
Discovery and synthesis of HIV integrase inhibitors: development of potent and orally bioavailable N-methyl pyrimidonesCristina Gardelli, Emanuela Nizi, Ester Muraglia, et al.
Pageof 2